Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Net Cash Flow (2024 - 2025)

Historic Net Cash Flow for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to -$2.8 million.

  • Connect Biopharma Holdings' Net Cash Flow rose 7837.16% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$58.7 million, marking a year-over-year decrease of 56284.0%. This contributed to the annual value of -$26.8 million for FY2024, which is 19835.8% down from last year.
  • According to the latest figures from Q3 2025, Connect Biopharma Holdings' Net Cash Flow is -$2.8 million, which was up 7837.16% from -$7.3 million recorded in Q2 2025.
  • Connect Biopharma Holdings' Net Cash Flow's 5-year high stood at $8.7 million during Q1 2024, with a 5-year trough of -$30.6 million in Q1 2025.